April, 2024
April 2024
M T W T F S S
1234567
891011121314
15161718192021
22232425262728
2930  
Yüksel Ürün: KEYNOTE-412 trial shows pembrolizumab + chemoradiotherapy doesn’t significantly improve event-free survival in unselected advanced head and neck squamous cell carcinoma vs placebo
Apr 2, 2024, 21:45

Yüksel Ürün: KEYNOTE-412 trial shows pembrolizumab + chemoradiotherapy doesn’t significantly improve event-free survival in unselected advanced head and neck squamous cell carcinoma vs placebo

Yüksel Ürün, Medical Oncologist at Ankara University, shared a post on X/Twitter:

“KEYNOTE-412 trial shows pembrolizumab + chemoradiotherapy doesn’t significantly improve event-free survival in unselected advanced head and neck squamous cell carcinoma vs placebo. More targeted approaches needed to enhance outcomes.”

Read further.
Source: Yüksel Ürün/X